Containers and methods for storing and admixing medical solutions
AssigneeBaxter International Inc.
InventorsMichael Becker, Michael Masterson, Freddy Desbrosses
Life of this patent
Estimating the term…
Abstract
Containers and methods for storing medical solutions are provided. More specifically, containers and methods for storing components that are to be admixed, together to create a final solution, one of the components comprising a lipid. In an embodiment, a container including an interior defining at least two chambers. The first chamber includes a lipid containing liquid. The second chamber includes a liquid that does not include a lipid. The first and second chambers are separated by an openable seal.
Claims65
A container for storing, sterilizing, and admixing medical solutions comprising:
- a first chamber;
- a second chamber;
- and
- a peelable seal separating the first chamber from the second chamber;
- wherein the container leaches one or more of:
- (i) less than 0.11 μg/ml of a semi-volatile compound;
- (ii) less than 0.023 μg/ml of aluminum;
- (iii) less than 5.6 μg/ml of an oligomeric propylene compound;
- and (iv) less than 5.6 μg/ml of an oligomeric ethylene vinyl acetate compound;
- into a lipid component contained and autoclaved in the container.
A container and medical solution comprising:
- a first chamber;
- a second chamber;
- a lipid component contained in one of the first and second chamber;
- and
- a peelable seal separating the first chamber from the second chamber;
- wherein the container leaches one or more of:
- (i) less than 0.11 μg/ml of a semi-volatile compound;
- (ii) less than 0.023 μg/ml of aluminum;
- (iii) less than 5.6 μg/ml of an oligomeric propylene compound;
- and
- (iv) less than 5.6 μg/ml of an oligomeric ethylene vinyl acetate compound, into the lipid component when autoclaved.
A medical product comprising:
- a container having a first chamber;
- a second chamber;
- and
- a peelable seal separating the first chamber from the second chamber;
- and
- a lipid component contained in one of the first and second chambers and having one or more of:
- (i) a semi-volatile compound concentration of less than 0.11 μg/ml;
- (ii) an aluminum concentration of less than 0.023 μg/ml;
- (iii) an oligomeric propylene concentration of less than 5.6 μg/ml;
- and
- (iv) an oligomeric ethylene vinyl acetate concentration of less than 5.6 μg/ml, after the container and lipid component contained in one of the first and second chamber have been autoclaved.
An autoclaved medical product comprising:
- a container having a peelable seal separating a first and second chamber;
- and
- a lipid component contained in one of the first and second chambers, the lipid component including one or more of:
- (i) less than 0.11 μg/ml of a semi-volatile compound;
- (ii) less than 0.023 μg/ml of aluminum;
- (iii) less than 5.6 μg/ml of an oligomeric propylene compound;
- and (iv) less than 5.6 μg/ml of an oligomeric ethylene vinyl acetate compound.
A container for storing and admixing medical solution comprising:
- a first chamber containing a lipid component having one or more of:
- (i) less than 0.11 μg/ml of a semi-volatile compound;
- (ii) less than 0.023 μg/ml of aluminum;
- (iii) less than 5.6 μg/ml of an oligomeric propylene compound;
- and (iv) less than 5.6 μg/ml of an oligomeric ethylene vinyl acetate compound;
- a second chamber;
- and
- a peelable seal separating the first chamber from the second chamber.
Dependencies are inferred from the claim text.